Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariola Peczkowska

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical Endocrinology|October 10, 2013
Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditionsRoland Därr, Christina Pamporaki, Mirko Peitzsch, et al.
European Journal of Endocrinology|November 6, 2014
Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytomaMariko Sue, Victoria Martucci, Florina Frey, et al.
JAMA|August 26, 2004
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutationsHartmut P H Neumann, Christian Pawlu, Mariola Peczkowska, et al.
Endokrynologia Polska|March 6, 2010
Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomasAleksandra Krawczyk, Kornelia Hasse-Lazar, Agnieszka Pawlaczek, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2009
Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndromeZoran Erlic, Michael M Hoffmann, Maren Sullivan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2008
Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1Mariola Peczkowska, Zoran Erlic, Michael M Hoffmann, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patientsZoran Erlic, Lisa Rybicki, Mariola Peczkowska, et al.
Endocrine-Related Cancer|October 31, 2013
Long-term prognosis of patients with pediatric pheochromocytomaBirke Bausch, Ulrich Wellner, Dirk Bausch, et al.
Hypertension (Dallas, Tex. : 1979)|March 10, 2020
Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions: The ARCADIA-POL StudyEwa Warchol-Celinska, Aleksander Prejbisz, Piotr Dobrowolski, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical Endocrinology|October 10, 2013
Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditionsRoland Därr, Christina Pamporaki, Mirko Peitzsch, et al.
European Journal of Endocrinology|November 6, 2014
Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytomaMariko Sue, Victoria Martucci, Florina Frey, et al.
JAMA|August 26, 2004
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutationsHartmut P H Neumann, Christian Pawlu, Mariola Peczkowska, et al.
Endokrynologia Polska|March 6, 2010
Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomasAleksandra Krawczyk, Kornelia Hasse-Lazar, Agnieszka Pawlaczek, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2009
Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndromeZoran Erlic, Michael M Hoffmann, Maren Sullivan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2008
Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1Mariola Peczkowska, Zoran Erlic, Michael M Hoffmann, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patientsZoran Erlic, Lisa Rybicki, Mariola Peczkowska, et al.
Endocrine-Related Cancer|October 31, 2013
Long-term prognosis of patients with pediatric pheochromocytomaBirke Bausch, Ulrich Wellner, Dirk Bausch, et al.
Hypertension (Dallas, Tex. : 1979)|March 10, 2020
Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions: The ARCADIA-POL StudyEwa Warchol-Celinska, Aleksander Prejbisz, Piotr Dobrowolski, et al.
Pageof 4